Are Amrutanjan Health Care Ltd latest results good or bad?
2026-05-09 19:15:36Amrutanjan Health Care Ltd's latest financial results for Q4 FY26 highlight a narrative of strong revenue growth alongside notable pressures on profitability. The company reported net sales of ₹149.77 crores, achieving a year-on-year growth of 10.60% compared to ₹135.41 crores in the same quarter last year. This marks the highest quarterly revenue in the company's history, reflecting sustained demand for its pain relief products and an expanding product portfolio. However, the operational metrics present a more complex picture. The net profit for the quarter stood at ₹16.19 crores, which represents a year-on-year growth of 6.65%, down from 11.13% in the previous year. This decline in profit growth indicates challenges in maintaining profitability despite revenue expansion. The operating margin, excluding other income, was reported at 17.06%, which shows a significant year-on-year improvement of 399 basis p...
Read full news article
Amrutanjan Health Care Q4 FY26: Strong Revenue Growth Masks Margin Pressures
2026-05-09 10:01:37Amrutanjan Health Care Ltd., the Chennai-based pain relief and wellness products manufacturer, delivered a mixed performance in Q4 FY26 (Mar'26), with net profit rising to ₹16.19 crores—a sequential increase of 6.67% from Q3 FY26 but a modest year-on-year growth of 6.65% from ₹15.18 crores in Mar'25. The company's market capitalisation stands at ₹1,598 crores, with shares trading at ₹548.80 as of May 08, 2026, down 1.75% on the day and 17.86% year-to-date.
Read full news article
Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-07 08:00:26Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a 2.74% gain on 7 May 2026, the stock’s momentum indicators and moving averages suggest a cautious outlook for investors navigating this small-cap pharmaceutical player’s evolving trend.
Read full news article
Amrutanjan Health Care Ltd is Rated Hold
2026-05-06 10:10:03Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Amrutanjan Health Care Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-05-06 08:00:09Amrutanjan Health Care Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent 7.54% decline to ₹533.50, coupled with downgrades in its technical grades and a revised Mojo Grade from Buy to Hold, reflects growing caution among investors amid mixed signals from momentum oscillators and moving averages.
Read full news article
Amrutanjan Health Care Ltd Hits Intraday Low Amid Price Pressure
2026-05-05 15:15:56Amrutanjan Health Care Ltd experienced significant intraday weakness on 5 May 2026, with the stock touching a low of Rs 532, marking a 7.8% decline from previous levels. The pharmaceutical company underperformed its sector and the broader market amid heightened volatility and persistent selling pressure.
Read full news article
Amrutanjan Health Care Ltd is Rated Hold
2026-04-25 10:10:03Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date perspective on its performance and outlook.
Read full news article
Amrutanjan Health Care Ltd Technical Momentum Shifts Amid Mixed Market Returns
2026-04-22 08:00:24Amrutanjan Health Care Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent 3.94% rise in the stock price to ₹564.55, the overall technical trend has softened from bearish to mildly bearish, prompting a downgrade in its Mojo Grade from Buy to Hold as of 18 Nov 2025.
Read full news article
Amrutanjan Health Care Ltd is Rated Hold
2026-04-14 10:10:02Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news articleBoard Meeting Intimation for Board Meeting Intimation For Audited Financial Results For The Quarter And Year Ended 31 March 2026 Recommendation Of Final Dividend For The Year 2025-26
30-Apr-2026 | Source : BSEAmrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year Ended 31 March 2026 Recommendation of Final Dividend for the year 2025-26
Product Launch
17-Apr-2026 | Source : BSEProduct Launch
Rephrasing Of ESOP
17-Apr-2026 | Source : BSERephrasing of ESOP
Corporate Actions
No Upcoming Board Meetings
Amrutanjan Health Care Ltd has declared 100% dividend, ex-date: 06 Feb 26
Amrutanjan Health Care Ltd has announced 1:2 stock split, ex-date: 13 Apr 18
No Bonus history available
No Rights history available






